These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2013213)

  • 1. Antimicrobial effects of the combination of ceftibuten and an orally absorbed penem SCH 29482.
    Chin NX; Gu JW; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(1):79-83. PubMed ID: 2013213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
    Jones RN
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S77-83. PubMed ID: 7567314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
    Wise R; Andrews JM; Ashby JP; Thornber D
    Diagn Microbiol Infect Dis; 1991; 14(1):45-52. PubMed ID: 2013210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A; Jungwirth R
    Infection; 1991; 19(5):353-62. PubMed ID: 1800377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in-vitro antibacterial activity of Sch 34343.
    Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
    Eliopoulos GM; Reiszner E; Moellering RC
    Antimicrob Agents Chemother; 1985 Jan; 27(1):28-32. PubMed ID: 3845792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study].
    Soussy CJ; Meyran M; Chanal M; Reverdy ME; Kitzis MD; Derlot E
    Pathol Biol (Paris); 1991 May; 39(5):396-402. PubMed ID: 1909017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
    Verbist L; Jacobs J; Hens K
    Diagn Microbiol Infect Dis; 1991; 14(1):53-61. PubMed ID: 1901535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiologic profile of ceftibuten, a new oral cephalosporin.
    Debbia EA; Pesce A; Chiesa M; Ricotta N; Schito GC
    Drugs Exp Clin Res; 1992; 18(4):129-39. PubMed ID: 1451643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
    Jones RN; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of the penem antibiotic Sch 34343 against gram-negative and gram-positive bacteria with special reference to multiresistant strains.
    Kayser FH; Novak J; Strässle A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():137-46. PubMed ID: 3849537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines.
    Jones RN; Barry AL
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):802-7. PubMed ID: 3145869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
    Bauernfeind A; Jungwirth R; Eberlein E; Klesel N; Adam F; Isert D; Limbert M; Markus A; Schrinner E; Seibert G
    J Antibiot (Tokyo); 1992 Apr; 45(4):505-20. PubMed ID: 1592683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
    Rolston KV; Alvarez ME; Hoy JF; Alderman HC; Ho DH; Bodey GP
    Chemotherapy; 1986; 32(6):506-14. PubMed ID: 3100147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.